Canopy Growth Corp (TSE:WEED - Get Free Report)'s share price was up 1.6% during mid-day trading on Monday . The stock traded as high as C$1.95 and last traded at C$1.93. Approximately 2,657,302 shares were traded during trading, an increase of 10% from the average daily volume of 2,419,484 shares. The stock had previously closed at C$1.90.
Analyst Upgrades and Downgrades
Separately, ATB Capital reduced their price target on Canopy Growth from C$3.20 to C$1.60 and set an "underperform" rating for the company in a report on Tuesday, June 3rd. Two analysts have rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Sell" and an average price target of C$1.55.
View Our Latest Stock Report on WEED
Canopy Growth Trading Up 1.6%
The firm has a market capitalization of C$602.14 million, a price-to-earnings ratio of -0.46, a price-to-earnings-growth ratio of -0.01 and a beta of 2.86. The company has a current ratio of 1.39, a quick ratio of 2.32 and a debt-to-equity ratio of 120.38. The company has a fifty day moving average price of C$1.79 and a 200-day moving average price of C$1.78.
Insiders Place Their Bets
In related news, Director David Angelo Lazzarato sold 15,701 shares of the business's stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of C$1.68, for a total value of C$26,307.34. Company insiders own 0.21% of the company's stock.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.